Document:

MAP Pharmaceuticals, Inc. Employee Stock Purchase Plan

 EXHIBIT 10.30 
 MAP PHARMACEUTICALS, INC. 
 EMPLOYEE STOCK PURCHASE PLAN 
 MAP Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby adopts the MAP Pharmaceuticals, Inc. Employee Stock Purchase
Plan, as amended from time to time (the “Plan”), effective as of the Effective Date (as defined herein). 
 1.
Purpose. The purposes of the Plan are as follows: 
 (a) To assist employees of the Company and its Designated Subsidiaries (as defined
below) in acquiring a stock ownership interest in the Company pursuant to a plan which is intended to qualify as an “employee stock purchase plan” within the meaning of Section 423(b) of the Internal Revenue Code of 1986, as amended.

 (b) To help employees provide for their future security and to encourage them to remain in the employment of the Company and its
Designated Subsidiaries. 
 2. Definitions. 
 (a) “Administrator” shall mean the administrator of the Plan, as determined pursuant to Section 14 hereof. 
 (b) “Board” shall mean the Board of Directors of the Company. 
 (c) “Code”
shall mean the Internal Revenue Code of 1986, as amended. 
 (d) “Committee” shall mean the committee appointed to
administer the Plan pursuant to Section 14 hereof. 
 (e) “Common Stock” shall mean the common stock of the Company.

 (f) “Company” shall mean MAP Pharmaceuticals, Inc., a Delaware corporation, and any successor by merger, consolidation or
otherwise. 
 (g) “Compensation” shall mean all base straight time gross earnings and commissions, exclusive of payments for
overtime, shift premium, incentive compensation, incentive payments, bonuses, expense reimbursements, fringe benefits and other compensation. 
 (h) “Designated Subsidiary” shall mean any Subsidiary which has been designated by the Administrator from time to time in its sole discretion as eligible to participate in the Plan. The Administrator may designate, or
terminate the designation of, a subsidiary as a Designated Subsidiary without the approval of the stockholders of the Company. 
 (i)
“Effective Date” shall mean the date on which the Company’s Registration Statement on Form S-1 filed with respect to the Company’s initial public offering becomes effective. 
  

 (j) “Eligible Employee” shall
mean an Employee of the Company or a Designated Subsidiary: (i) who does not, immediately after the Option is granted, own stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of
the Company, a Parent or a Subsidiary (as determined under Section 423(b)(3) of the Code); (ii) whose customary employment is for more than twenty (20) hours per week; and (iii) whose customary employment is for more than five
(5) months in any calendar year. For purposes of clause (i), the rules of Section 424(d) of the Code with regard to the attribution of stock ownership shall apply in determining the stock ownership of an individual, and stock which an
employee may purchase under outstanding options shall be treated as stock owned by the employee. For purposes of the Plan, the employment relationship shall be treated as continuing intact while the individual is on sick leave or other leave of
absence approved by the Company or Designated Subsidiary and meeting the requirements of Treasury Regulation Section 1.421-7(h)(2). Where the period of leave exceeds ninety (90) days and the individual’s right to reemployment is not
guaranteed either by statute or by contract, the employment relationship shall be deemed to have terminated on the ninety-first (91st) day of such
leave. 
 (k) “Employee” shall mean any person who renders services to the Company or a Subsidiary in the status of
an employee within the meaning of Code Section 3401(c). “Employee” shall not include any director of the Company or a Subsidiary who does not render services to the Company or a Subsidiary in the status of an employee within the
meaning of Code Section 3401(c). 
 (l) “Enrollment Date” shall mean the first Trading Day of each Offering Period. The
Enrollment Date for the first Offering Period under the Plan shall be the Effective Date. 
 (m) “Exercise Date” shall mean
the last Trading Day of each Offering Period. 
 (n) “Fair Market Value” shall mean, as of any date, the value of Common
Stock determined as follows: 
 (i) If the Common Stock is listed on any established stock exchange or a national market system, its Fair
Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange or system for such date, or if no bids or sales were reported for such date, then the closing sales price (or the
closing bid, if no sales were reported) on the trading date immediately prior to such date during which a bid or sale occurred, in each case, as reported in The Wall Street Journal or such other source as the Administrator deems reliable;

 (ii) If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, its Fair Market Value
shall be the mean of the closing bid and asked prices for the Common Stock on such date, or if no closing bid and asked prices were reported for such date, the date immediately prior to such date during which closing bid and asked prices were quoted
for the Common Stock, in each case, as reported in The Wall Street Journal or such other source as the Administrator deems reliable; 
 (iii) In the absence of an established market for the Common Stock, the Fair Market Value thereof shall be determined in good faith by the Administrator; or 
  

 2 

 (iv) For purposes of the first Offering Period under the Plan, the Fair Market Value on the Enrollment
Date shall be the initial price to the public as set forth in the final prospectus included within the registration statement on Form S-1 filed with the Securities and Exchange Commission for the initial public offering of the Company’s Common
Stock (the “Registration Statement”). 
 (o) “Offering Date” shall mean each May 21 and November 21;
provided, however, that the first Offering Date under the Plan shall be the Effective Date. 
 (p) “Offering Period” shall
mean subject to Section 24, each six (6) month period beginning on an Offering Date and ending on the next succeeding Exercise Date; provided, however, that the first Offering Period shall commence on the Effective Date and end on
May 20, 2008. The duration and timing of Offering Periods may be changed pursuant to Section 4 of this Plan. 
 (q)
“Parent” means any corporation, other than the Company, in an unbroken chain of corporations ending with the Company if, at the time of the determination, each of the corporations other than the Company owns stock possessing 50% or
more of the total combined voting power of all classes of stock in one of the other corporations in such chain. 
 (r)
“Plan” shall mean this MAP Pharmaceuticals, Inc. Employee Stock Purchase Plan, as may be amended from time to time. 
 (s)
“Purchase Price” shall mean 85% of the Fair Market Value of a share of Common Stock on the Enrollment Date or on the Exercise Date, whichever is lower; provided, however, that the Purchase Price may be adjusted by the
Administrator pursuant to Section 20; provided, further, that the Purchase Price shall not be less than the par value of a share of Common Stock. 
 (t) “Subsidiary” shall mean any corporation, other than the Company, in an unbroken chain of corporations beginning with the Company if, at the time of the determination, each of the corporations
other than the last corporation in an unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. 
 (u) “Trading Day” shall mean a day on which national stock exchanges and the Nasdaq System are open for trading. 
 3. Eligibility. 
 (a) Any Eligible
Employee who shall be employed by the Company or a Designated Subsidiary on a given Enrollment Date for an Offering Period shall be eligible to participate in the Plan during such Offering Period, subject to the requirements of Section 5 and
the limitations imposed by Section 423(b) of the Code. 
 (b) Each person who, during the course of an Offering Period, first becomes an
Eligible Employee subsequent to the Enrollment Date will be eligible to become a participant in the Plan on the first Enrollment Date following the day on which such person becomes an Eligible Employee, subject to the requirements of Section 5
and the limitations imposed by Section 423(b) of the Code. 
  

 3 

 (c) No Eligible Employee shall be granted an option under the Plan which permits his rights to purchase
stock under the Plan, and to purchase stock under all other employee stock purchase plans of the Company, any Parent or any Subsidiary subject to the Section 423, to accrue at a rate which exceeds $25,000 of fair market value of such stock
(determined at the time the option is granted) for each calendar year in which the option is outstanding at any time. For purpose of the limitation imposed by this subsection, the right to purchase stock under an option accrues when the option (or
any portion thereof) first becomes exercisable during the calendar year, the right to purchase stock under an option accrues at the rate provided in the option, but in no case may such rate exceed $25,000 of fair market value of such stock
(determined at the time such option is granted) for any one calendar year, and a right to purchase stock which has accrued under an option may not be carried over to any option. This limitation shall be applied in accordance with
Section 423(b)(8) of the Code and the Treasury Regulations thereunder. 
 4. Offering Periods. Subject to Section 24, the
Plan shall be implemented by successive Offering Periods which shall continue until the Plan expires or is terminated in accordance with Section 20 hereof. The Administrator shall have the power to change the duration of Offering Periods
(including the commencement dates thereof) with respect to future offerings without stockholder approval if such change is announced at least five (5) days prior to the scheduled beginning of the first Offering Period to be affected thereafter.
In no event may an Offering Period exceed twenty-seven (27) months in duration. 
 5. Participation. 
 (a) Each Eligible Employee who is employed by the Company or a Designated Subsidiary on the calendar day immediately preceding the Effective Date shall
automatically become a participant in the Plan with respect to the first Offering Period. Each such participant shall be granted an option to purchase shares of Common Stock and shall be enrolled in such first Offering Period to the extent of
fifteen percent (15%) of his or her Compensation for the pay days during the first Offering Period (or, if less, the maximum amount of contributions permitted to be made by such participant for such Offering Period by payroll deduction under
the terms of this Plan). Participants wishing to purchase shares of Common Stock during the first Offering Period may do so by making a lump sum cash payment to the Company not later than ten (10) calendar days before the Exercise Date of such
Offering Period, and each such payment may be made in an amount not exceeding fifteen percent (15%) of such participant’s Compensation for the pay days occurring during such Offering Period and occurring prior to such lump sum payment;
provided, however, that such participant shall not be required to make such lump sum cash payments, or exercise all or any portion of such option to purchase shares of Common Stock by making such lump sum payments. Following the
Effective Date, each such participant may, during the period designated from time to time by the Administrator for such purpose, elect to make such contributions (or a lesser amount of contributions) for the first Offering Period by payroll
deductions in accordance with Section 6, in lieu of making contributions in such lump sum cash payments under this subsection (a), or may elect to make no contributions for such Offering Period; provided, however, that, to make
contributions by payroll deductions, such 

  

 4 

 
participant must complete the form of subscription agreement provided by the Company for the first Offering Period under this Plan. If (i) during the
first Offering Period, such a participant elects to make contributions by payroll deduction, or elects to make no contributions for such Offering Period, or (ii) on or prior to the tenth (10th
) calendar day before the Exercise Date of the first Offering Period, such a participant fails to make any lump sum cash payment, such participant shall be deemed to have elected not to make
contributions by lump sum payment with respect to such first Offering Period. Except as described in subsection (e) below, a participant may not make contributions by lump sum payment for any Offering Period other than the first Offering
Period. 
 (b) Following the first Offering Period, an Eligible Employee may become a participant in the Plan by completing a
subscription agreement authorizing payroll deductions in the form of Exhibit A to this Plan and filing it with the Company’s payroll office fifteen (15) days (or such shorter or longer period as may be determined by the
Administrator, in its sole discretion) prior to the applicable Enrollment Date. 
 (c) Each person who, during the course of an Offering
Period, first becomes an Eligible Employee subsequent to the Enrollment Date will be eligible to become a participant in the Plan on the first Enrollment Date following the day on which such person becomes an Eligible Employee. Such person may
become a participant in the Plan by completing a subscription agreement authorizing payroll deductions in the form of Exhibit A to this Plan and filing it with the Company’s payroll office fifteen (15) days (or such shorter or
longer period as may be determined by the Administrator, in its sole discretion) prior to the first day of any Offering Period following the date such person becomes an Eligible Employee. 
 (d) Except as provided in subsection (a), payroll deductions for a participant shall commence on the first payroll following the Enrollment Date and
shall end on the last payroll in the Offering Period to which such authorization is applicable, unless sooner terminated by the participant as provided in Section 10 hereof. 
 (e) During a leave of absence approved by the Company or a Subsidiary and meeting the requirements of Treasury Regulation Section 1.421-7(h)(2), a
participant may continue to participate in the Plan by making cash payments to the Company on each pay day equal to the amount of the participant’s payroll deductions under the Plan for the pay day immediately preceding the first day of such
participant’s leave of absence. If a leave of absence is unapproved or fails to meet the requirements of Treasury Regulation Section 1.421-7(h)(2), the participant will cease automatically to participate in the Plan. In such event, the
company will automatically cease to deduct the participant’s payroll under the Plan. The Company will pay to the participant his or her total payroll deductions for the Offering Period, in cash in one lump sum (without interest), as soon as
practicable after the participant ceases to participate in the Plan. 
 (f) A participant’s completion of a subsequent agreement will
enroll such participant in the Plan for each successive Offering Period on the terms contained therein until the participant either submits a new subscription agreement, withdraws from participation under the Plan as provide in Section 10
hereof or otherwise becomes ineligible to participate in the Plan. 
  

 5 

 6. Payroll Deductions. 
 (a) At the time a participant files his or her subscription agreement, he or she shall elect to have payroll deductions made on each pay day during the
Offering Period in an amount from one percent (1%) to fifteen percent (15%) of the Compensation which he or she receives on each pay day during the Offering Period. 
 (b) All payroll deductions made for a participant shall be credited to his or her account under the Plan and shall be withheld in whole percentages only.
Except as described in Section 5(a) hereof, a participant may not make any additional payments into such account. 
 (c) A participant
may discontinue his or her participation in the Plan as provided in Section 10 hereof, or may increase or decrease the rate of his or her payroll deductions during the Offering Period by completing or filing with the Company a new subscription
agreement authorizing a change in payroll deduction rate. The Administrator may, in its discretion, limit the number of participation rate changes during any Offering Period. The change in rate shall be effective with the first full payroll period
following five (5) business days after the Company’s receipt of the new subscription agreement (or such shorter or longer period as may be determined by the Administrator, in its sole discretion). 
 (d) Notwithstanding the foregoing, to the extent necessary to comply with Section 423(b)(8) of the Code and Section 3(c) hereof, a
participant’s payroll deductions may be decreased to zero percent (0%) at any time during an Offering Period. 
 (e) At the time the
option is exercised, in whole or in part, or at the time some or all of the Company’s Common Stock issued under the Plan is disposed of, the participant must make adequate provision for the Company’s federal, state, or other tax
withholding obligations, if any, which arise upon the exercise of the option or the disposition of the Common Stock. At any time, the Company may, but shall not be obligated to, withhold from the participant’s compensation the amount necessary
for the Company to meet applicable withholding obligations, including any withholding required to make available to the Company any tax deductions or benefits attributable to sale or early disposition of Common Stock by the Employee. 
 7. Grant of Option. On the Enrollment Date of each Offering Period, each Eligible Employee participating in such Offering Period shall be granted
an option to purchase on the Exercise Date for such Offering Period (at the applicable Purchase Price) up to a number of shares of the Company’s Common Stock determined by dividing such participant’s payroll deductions accumulated prior to
such Exercise Date and retained in the participant’s account as of the Exercise Date by the applicable Purchase Price; provided, however, that in no event shall a participant be permitted to purchase during each Offering Period more than fifty
thousand (50,000) shares of the Company’s Common Stock (subject to any adjustment pursuant to Section 19); and provided, further, that such purchase shall be subject to the limitations set forth in Sections 3(c) and 13 hereof.
The Administrator may, for future Offering Periods, increase or decrease, in its absolute discretion, the maximum number of shares of the Company’s Common Stock a participant may purchase during each Offering Period. Exercise of the option
shall occur as provided in Section 8 hereof, unless the participant has withdrawn pursuant to Section 10 hereof or otherwise becomes ineligible to participate in the Plan. The option shall expire on the last day of the Offering Period.

  

 6 

 8. Exercise of Option. 
 (a) Unless a participant withdraws from the Plan as provided in Section 10 hereof or otherwise becomes ineligible to participate in the Plan, his or
her option for the purchase of shares shall be exercised automatically on the Exercise Date, and the maximum number of full shares subject to the option shall be purchased for such participant at the applicable Purchase Price with the accumulated
payroll deductions in his or her account. No fractional shares shall be purchased; any payroll deductions accumulated in a participant’s account which are not sufficient to purchase a full share shall be retained in the participant’s
account for the subsequent Offering Period. During a participant’s lifetime, a participant’s option to purchase shares hereunder is exercisable only by him or her. 
 (b) If the Administrator determines that, on a given Exercise Date, the number of shares with respect to which options are to be exercised may exceed
(i) the number of shares of Common Stock that were available for sale under the Plan on the Enrollment Date of the applicable Offering Period, or (ii) the number of shares available for sale under the Plan on such Exercise Date, the
Administrator may in its sole discretion (x) provide that the Company shall make a pro rata allocation of the shares of Common Stock available for purchase on such Enrollment Date or Exercise Date, as applicable, in as uniform a manner as shall
be practicable and as it shall determine in its sole discretion to be equitable among all participants exercising options to purchase Common Stock on such Exercise Date, and continue all Offering Periods then in effect, or (y) provide that the
Company shall make a pro rata allocation of the shares available for purchase on such Enrollment Date or Exercise Date, as applicable, in as uniform a manner as shall be practicable and as it shall determine in its sole discretion to be equitable
among all participants exercising options to purchase Common Stock on such Exercise Date, and terminate any or all Offering Periods then in effect pursuant to Section 20 hereof. The Company may make pro rata allocation of the shares available
on the Enrollment Date of any applicable Offering Period pursuant to the preceding sentence, notwithstanding any authorization of additional shares for issuance under the Plan by the Company’s stockholders subsequent to such Enrollment Date.
The balance of the amount credited to the account of each participant which has not been applied to the purchase of shares of stock shall be paid to such participant in one lump sum in cash as soon as reasonably practicable after the Exercise Date,
without any interest thereon. 
 9. Deposit of Shares. As promptly as practicable after each Exercise Date on which a purchase of
shares occurs, the Company may arrange for the deposit, into each participant’s account with any broker designated by the Company to administer this Plan, of the number of shares purchased upon exercise of his or her option. 
 10. Withdrawal. 
 (a) A participant
may withdraw all but not less than all of the payroll deductions credited to his or her account and not yet used to exercise his or her option under the Plan at any time by giving written notice to the Company in the form of Exhibit A to this
Plan. All of the 

  

 7 

 
participant’s payroll deductions credited to his or her account during the Offering Period shall be paid to such participant as soon as reasonably
practicable after receipt of notice of withdrawal and such participant’s option for the Offering Period shall be automatically terminated, and no further payroll deductions for the purchase of shares shall be made for such Offering Period. If a
participant withdraws from an Offering Period, payroll deductions shall not resume at the beginning of the succeeding Offering Period unless the participant delivers to the Company a new subscription agreement. 
 (b) A participant’s withdrawal from an Offering Period shall not have any effect upon his or her eligibility to participate in any similar plan
which may hereafter be adopted by the Company or in succeeding Offering Periods which commence after the termination of the Offering Period from which the participant withdraws. 
 11. Termination of Employment. Upon a participant’s ceasing to be an Eligible Employee, for any reason, he or she shall be deemed to have
elected to withdraw from the Plan and the payroll deductions credited to such participant’s account during the Offering Period shall be paid to such participant or, in the case of his or her death, to the person or persons entitled thereto
under Section 15 hereof, as soon as reasonably practicable and such participant’s option for the Offering Period shall be automatically terminated. 
 12. Interest. No interest shall accrue on the payroll deductions or lump sum contributions of a participant in the Plan. 
 13. Shares Subject to Plan. 
 (a) Subject to adjustment upon changes in capitalization of the Company
as provided in Section 19 hereof, the maximum initial number of shares of the Company’s Common Stock which shall be made available for sale under the Plan shall be five hundred thousand (500,000) shares. In addition to the foregoing,
subject to Section 19 hereof, commencing on the first day of the Company’s 2008 fiscal year and on the first day of each fiscal year thereafter during the term of the Plan, the number of shares of the Company’s Common Stock which
shall be made available for sale under the Plan shall be increased by that number of shares of the Company’s Common Stock equal to the least of (i) one percent (1%) of the Company’s outstanding shares of Common Stock on such
date, (ii) two hundred fifteen thousand (215,000) shares or (iii) a lesser amount determined by the Board. Notwithstanding the foregoing, in no event shall the aggregate number of shares reserved for issuance under the Plan, during
the term of the Plan, exceed five million (5,000,000) shares of the Company’s Common Stock during the term of the Plan, subject to adjustment as provided in Section 19 hereof. If any right granted under the Plan shall for any reason
terminate without having been exercised, the Common Stock not purchased under such right shall again become available for issuance under the Plan. The stock subject to the Plan may be unissued shares or reacquired shares, bought on the market or
otherwise. 
 (b) If any right granted under the Plan shall for any reason terminate without having been exercised, the Common Stock not
purchased under such right shall again become available for issuance under the Plan. The stock subject to the Plan may be unissued shares or reacquired shares, bought on the market or otherwise. 
  

 8 

 (c) With respect to shares of stock subject to an option granted under the Plan, a participant shall not
be deemed to be a stockholder of the Company, and the participant shall not have any of the rights or privileges of a stockholder, until such shares have been issued to the participant or his or her nominee following exercise of the
participant’s option. No adjustments shall be made for dividends (ordinary or extraordinary, whether in cash securities, or other property) or distribution or other rights for which the record date occurs prior to the date of such issuance,
except as otherwise expressly provided herein. 
 14. Administration. 
 (a) The Plan shall be administered by the Board unless and until the Board delegates administration to a Committee as set forth below. The Board may
delegate administration of the Plan to a Committee comprised of two or more members of the Board, each of whom is a “non-employee director” within the meaning of Rule 16b-3 which has been adopted by the Securities and Exchange Commission
under the Securities Exchange Act of 1934, as amended, and which is otherwise constituted to comply with applicable law, and the term “Committee” shall apply to any persons to whom such authority has been delegated. If administration is
delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the powers theretofore possessed by the Board, including the power to delegate to a subcommittee any of the administrative powers the Committee is
authorized to exercise, subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. Each member of the Committee shall serve for a term commencing on a date specified by
the Board and continuing until the member dies or resigns or is removed from office by the Board. References in this Plan to the “Administrator” shall mean the Board unless administration is delegated to a Committee or subcommittee, in
which case references in this Plan to the Administrator shall thereafter be to the Committee or subcommittee. 
 (b) It shall be the duty of
the Administrator to conduct the general administration of the Plan in accordance with the provisions of the Plan. The Administrator shall have the power to interpret the Plan and the terms of the options and to adopt such rules for the
administration, interpretation, and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. The Administrator at its option may utilize the services of an agent to assist in the administration of the
Plan including establishing and maintaining an individual securities account under the Plan for each participant. In its absolute discretion, the Board may at any time and from time to time exercise any and all rights and duties of the Administrator
under the Plan. 
 (c) All expenses and liabilities incurred by the Administrator in connection with the administration of the Plan shall be
borne by the Company. The Administrator may, with the approval of the Board, employ attorneys, consultants, accountants, appraisers, brokers or other persons. The Administrator, the Company and its officers and directors shall be entitled to rely
upon the advice, opinions or valuations of any such persons. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon all participants, the Company and all other interested
persons. No member of the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or the options, and all members of the Board shall be fully protected by the Company in respect to
any such action, determination, or interpretation. 
  

 9 

 15. Designation of Beneficiary. 
 (a) A participant may file a written designation of a beneficiary who is to receive any shares and cash, if any, from the participant’s account under
the Plan in the event of such participant’s death subsequent to an Exercise Date on which the option is exercised but prior to delivery to such participant of such shares and cash. In addition, a participant may file a written designation of a
beneficiary who is to receive any cash from the participant’s account under the Plan in the event of such participant’s death prior to exercise of the option. If a participant is married and the designated beneficiary is not the spouse,
spousal consent shall be required for such designation to be effective. 
 (b) Such designation of beneficiary may be changed by the
participant at any time by written notice to the Company. In the event of the death of a participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such participant’s death, the Company shall
deliver such shares and/or cash to the executor or administrator of the estate of the participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares
and/or cash to the spouse or to any one or more dependents or relatives of the participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. 
 16. Transferability. Neither payroll deductions credited to a participant’s account nor any rights with regard to the exercise of an option
or to receive shares under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Section 15 hereof) by the participant. Any such attempt at
assignment, transfer, pledge or other disposition shall be without effect, except that the Company may treat such act as an election to withdraw funds from an Offering Period in accordance with Section 10 hereof. 
 17. Use of Funds. All payroll deductions received or held by the Company under the Plan may be used by the Company for any corporate purpose, and
the Company shall not be obligated to segregate such payroll deductions. 
 18. Reports. Individual accounts shall be maintained for
each participant in the Plan. Statements of account shall be given to participating Employees at least annually, which statements shall set forth the amounts of payroll deductions, the Purchase Price, the number of shares purchased and the remaining
cash balance, if any. 
 19. Adjustments. Upon Changes in Capitalization, Dissolution, Liquidation, Merger or Asset Sale. 

(a) Changes in Capitalization. In the event that any dividend or other distribution, reorganization, merger, consolidation, combination,
repurchase, or exchange of Common Stock or other securities of the Company, or other change in the corporate structure of the Company affecting the Common Stock occurs such that an adjustment is determined by the Administrator 

  

 10 

 
(in its sole discretion) to be appropriate in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available
under the Plan, then the Administrator shall, in such manner as it may deem equitable, adjust the number and class of Common Stock which have been authorized for issuance under this Plan but have not yet been placed under option, the number of
shares subject to the Plan and limitations provided in Section 13, the maximum number of shares each participant may purchase each Offering Period (pursuant to Section 7), the number and class of Common Stock covered by each outstanding
option, the purchase price per share of Common Stock covered by each option which has not yet been exercised. 
 (b) Equity
Restructuring. In connection with the occurrence of any Equity Restructuring, and notwithstanding anything to the contrary in Section 19(a), the number and type of securities subject to each outstanding option and the price per share
thereof, if applicable, will be equitably adjusted by the Administrator. The adjustments provided under this Section 19(b) shall be nondiscretionary and shall be final and binding on the affected participants and the Company. “Equity
Restructuring” means a non-reciprocal transaction (i.e. a transaction in which the Company does not receive consideration or other resources in respect of the transaction approximately equal to and in exchange for the consideration or
resources the Company is relinquishing in such transaction) between the Company and its stockholders, such as a stock split, spin-off, rights offering, nonrecurring stock dividend or recapitalization through a large, nonrecurring cash dividend, that
affects the shares of Common Stock (or other securities of the Company) or the share price of Common Stock (or other securities) and causes a change in the per share value of the Common Stock underlying outstanding options. 
 (c) Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Offering Period then in progress shall
be shortened by setting a new Exercise Date (the “New Exercise Date”), and shall terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the Administrator. The New
Exercise Date shall be before the date of the Company’s proposed dissolution or liquidation. The Administrator shall notify each participant in writing, at least ten (10) business days prior to the New Exercise Date, that the Exercise Date
for the participant’s option has been changed to the New Exercise Date and that the participant’s option shall be exercised automatically on the New Exercise Date, unless prior to such date the participant has withdrawn from the Offering
Period as provided in Section 10 hereof. 
 (d) Merger or Asset Sale. In the event of a proposed sale of all or substantially all
of the assets of the Company, or the merger of the Company with or into another corporation, each outstanding option shall be assumed or an equivalent option substituted by the successor corporation or a Parent or Subsidiary of the successor
corporation. In the event that the successor corporation refuses to assume or substitute for the option, any Offering Period then in progress shall be shortened by setting a New Exercise Date and any Offering Periods then in progress shall end on
the New Exercise Date. The New Exercise Date shall be before the date of the Company’s proposed sale or merger. The Administrator shall notify each participant in writing, at least ten (10) business days prior to the New Exercise Date,
that the Exercise Date for the participant’s option has been changed to the New Exercise Date and that the participant’s option shall be exercised automatically on the New Exercise Date, unless prior to such date the participant has
withdrawn from the Offering Period as provided in Section 10 hereof. 
  

 11 

 20. Amendment or Termination. 
 (a) The Board may at any time and for any reason terminate or amend the Plan. Except as provided in Section 19 hereof, no such termination can affect
options previously granted, provided that an Offering Period may be terminated by the Board if the Board determines that the termination of the Offering Period or the Plan is in the best interests of the Company and its stockholders. Except as
provided in Section 19 and this Section 20 hereof, no amendment may make any change in any option theretofore granted which adversely affects the rights of any participant without the consent of such participant. To the extent necessary to
comply with Section 423 of the Code (or any successor rule or provision or any other applicable law, regulation or stock exchange rule), the Company shall obtain stockholder approval in such a manner and to such a degree as required.

 (b) Without stockholder consent and without regard to whether any participant rights may be considered to have been “adversely
affected,” the Administrator shall be entitled to change the Offering Periods, limit the frequency and/or number of changes in the amount withheld during an Offering Period, establish the exchange ratio applicable to amounts withheld in a
currency other than U.S. dollars, permit payroll withholding in excess of the amount designated by a participant in order to adjust for delays or mistakes in the Company’s processing of properly completed withholding elections, establish
reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each participant properly correspond with amounts withheld from the participant’s
Compensation, and establish such other limitations or procedures as the Administrator determines in its sole discretion advisable which are consistent with the Plan. 
 (c) In the event the Board determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences, the Board may, in its discretion and, to the extent necessary or desirable,
modify or amend the Plan to reduce or eliminate such accounting consequence including, but not limited to: 
 (i) altering the Purchase Price
for any Offering Period including an Offering Period underway at the time of the change in Purchase Price; 
 (ii) shortening any Offering
Period so that the Offering Period ends on a new Exercise Date, including an Offering Period underway at the time of the Administrator action; and 
 (iii) allocating shares. 
 Such modifications or amendments shall not require stockholder approval or the consent of any Plan
participants. 
 21. Notices. All notices or other communications by a participant to the Company under or in connection with the Plan
shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof. 
  

 12 

 22. Conditions To Issuance of Shares. The Company shall not be required to issue or deliver any
certificate or certificates for shares of Stock purchased upon the exercise of options prior to fulfillment of all the following conditions: 
 (a) The admission of such shares to listing on all stock exchanges, if any, on which is then listed; and 
 (b) The completion of
any registration or other qualification of such shares under any state or federal law or under the rulings or regulations of the Securities and Exchange Commission or any other governmental regulatory body, which the Administrator shall, in its
absolute discretion, deem necessary or advisable; and 
 (c) The obtaining of any approval or other clearance from any state or federal
governmental agency which the Administrator shall, in its absolute discretion, determine to be necessary or advisable; and 
 (d) The payment
to the Company of all amounts which it is required to withhold under federal, state or local law upon exercise of the option; and 
 (e) The
lapse of such reasonable period of time following the exercise of the Option as the Administrator may from time to time establish for reasons of administrative convenience. 
 23. Term of Plan. The Plan shall become effective on the Effective Date. Subject to
approval by the stockholders of the Company in accordance with this Section, the Plan shall be in effect until the tenth (10th) anniversary of the
date of the initial adoption of the Plan by the Board, unless sooner terminated under Section 20 hereof. The Plan shall be submitted for the approval of the Company’s stockholders within twelve (12) months after the date of the
initial adoption of the Plan by the Board. 
 24. Equal Rights and Privileges. All Eligible Employees of the Company (or of any
Designated Subsidiary) will have equal rights and privileges under this Plan so that this Plan qualifies as an “employee stock purchase plan” within the meaning of Section 423 of the Code or applicable Treasury regulations thereunder.
Any provision of this Plan that is inconsistent with Section 423 or applicable Treasury regulations will, without further act or amendment by the Company, the Board or the Administrator, be reformed to comply with the equal rights and
privileges requirement of Section 423 or applicable Treasury regulations. 
 25. No Employment Rights. Nothing in the Plan shall
be construed to give any person (including any Eligible Employee or participant) the right to remain in the employ of the Company, a Parent or a Subsidiary or to affect the right of the Company, any Parent or any Subsidiary to terminate the
employment of any person (including any Eligible Employee or participant) at any time, with or without cause. 
 26. Notice of Disposition
of Shares. Each participant shall give prompt notice to the Company of any disposition or other transfer of any shares of stock purchased upon exercise of an option if such disposition or transfer is made: (a) within two (2) years from
the Enrollment Date of the Offering Period in which the shares were purchased or (b) within one (1) year after 

  

 13 

 
the Exercise Date on which such shares were purchased. Such notice shall specify the date of such disposition or other transfer and the amount realized, in
cash, other property, assumption of indebtedness or other consideration, by the participant in such disposition or other transfer. 
 27.
Governing Law. The validity and enforceability of this Plan shall be governed by and construed in accordance with the laws of the State of Delaware without regard to otherwise governing principles of conflicts of law. 
  

 14Form of 6.5% Senior Convertible Promissory Note

 Exhibit 4.1 
 [FORM OF CONVERTIBLE PROMISSORY NOTE] 
 [U.S.][NEITHER THIS SECURITY NOR THE SECURITIES ISSUABLE UPON CONVERSION OF THIS
SECURITY (THE “SECURITIES”) HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY. ] 
 [EU][NEITHER THIS SECURITY NOR THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY (THE “SECURITIES”) HAVE BEEN REGISTERED WITH
THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THESE SECURITIES ARE BEING OFFERED
AND SOLD ONLY PURSUANT TO OFFERS AND SALES THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF REGULATION S UNDER THE SECURITIES ACT. THE SECURITIES MAY NOT BE RE-OFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED
OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS THE TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, REGISTRATION. THE HOLDER OF THIS SECURITY BY ITS ACCEPTANCE HEREOF AGREES THAT IT WILL ONLY OFFER, SELL OR OTHERWISE TRANSFER THESE SECURITIES, PRIOR
TO THE DATE WHICH IS TWO YEARS AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF (OR, AS TO ANY CONVERSION OF THIS SECURITY, THE DATE OF PURCHASE OF ANY SECURITIES THAT MAY BE RECEIVED UPON SUCH CONVERSION) AND THE LAST DATE ON WHICH THE COMPANY OR
ANY AFFILIATE OF THE COMPANY WAS THE OWNER OF THIS SECURITY (OR ANY PREDECESSOR OF THIS SECURITY OR ANY SECURITIES THAT MAY BE RECEIVED UPON THE CONVERSION HEREOF): (A) TO THE COMPANY, (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN
DECLARED EFFECTIVE UNDER THE SECURITIES ACT, (C) PURSUANT TO OFFERS AND SALES TO NON-U.S. PERSONS THAT OCCUR OUTSIDE THE UNITED STATES WITHIN THE MEANING OF REGULATION S UNDER THE SECURITIES ACT IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE
904 UNDER THE SECURITIES ACT, OR (D) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, SUBJECT TO THE COMPANY’S RIGHT PRIOR TO ANY OFFER, SALE OR TRANSFER PURSUANT TO CLAUSE (C) OR
(D) TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATES AND/OR OTHER INFORMATION REASONABLY SATISFACTORY TO THE COMPANY. THE HOLDER OF THIS SECURITY BY ITS ACCEPTANCE HEREOF FURTHER AGREES NOT TO ENGAGE IN HEDGING TRANSACTIONS
INVOLVING THESE SECURITIES UNLESS SUCH TRANSACTIONS MEET THE REQUIREMENTS AND COMPLY WITH THE SECURITIES ACT.] 

					
	 No. B-[            ]
	  	[$	_____________	]
	Original Issue Date:     September 19, 2007	  			

 SYNOVA HEALTHCARE GROUP, INC. 
 6.5% SENIOR CONVERTIBLE PROMISSORY NOTE, SERIES B, DUE 
 SEPTEMBER 19, 2012

 THIS NOTE is one of a series of duly authorized and issued notes of Synova Healthcare Group, Inc., a Nevada corporation (the
“Company”), designated as its 6.5% Senior Convertible Promissory Notes, Series B, due September 19, 2012, in the original aggregate notional principal amount of Five Million Dollars ($5,000,000)
(collectively, the “Notes” and each Note comprising the Notes, a “Note”)(certain of which may be denominated in Euros). 
 FOR VALUE RECEIVED, the Company promises to pay to _______________________, a _________________________, or its registered assigns (the
“Investor”), the principal sum of ___________________ [DOLLARS ($____________)] [EUROS
(€                    )], on September 19, 2012 or such earlier date as this Note is required to be repaid as provided hereunder
(the “Maturity Date”), and to pay interest to the Investor on the principal amount of this Note outstanding from time to time in accordance with the provisions hereof. All holders of Notes are referred to
collectively, as the “Investors.” This Note is subject to the following additional provisions: 
 1.
Definitions. In addition to the terms defined elsewhere in this Note: (a) capitalized terms that are used but not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement, dated as of
September 19, 2007, among the Company and the Investors identified therein with respect to the purchase and sale of the Note (the “Purchase Agreement”), and (b) the following terms have the meanings
indicated below: 
 “Alternate Consideration” has the meaning set forth in Section 10(c) of this Note. 
 “Bankruptcy Code” means Title 11 of the United States Code (11 U.S.C. 101 et seq.), as amended from time to time (including any
successor statute) and all rules and regulations promulgated thereunder. 
 “Bankruptcy Event” means any of the following
events: (a) the Company or any Subsidiary commences a case or other proceeding under any Bankruptcy Law relating to the Company or any Subsidiary thereof; (b) there is commenced against the Company or any Subsidiary any such case or
proceeding that is not dismissed within 60 days after commencement; (c) the Company or any subsidiary is adjudicated by a court of competent jurisdiction insolvent or bankrupt or any order of relief or other order approving any such case or
proceeding is entered; (d) the Company or any Subsidiary suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or stayed 

  

 2 

 
within 60 days; (e) under applicable law the Company or any Subsidiary makes a general assignment for the benefit of creditors; (f) the
Company or any Subsidiary fails to pay, or states that it is unable to pay or is unable to pay, its debts generally as they become due; (g) the Company or any Subsidiary calls a meeting of its creditors with a view to arranging a composition,
adjustment or restructuring of its debts; or (h) the Company or any Subsidiary, by any act or failure to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action for the
purpose of effecting any of the foregoing. 
 “Bankruptcy Law” means the Bankruptcy Code of the United States and all other
liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, fraudulent conveyance or transfer, reorganization, or similar state or Federal debtor relief laws, statutes,
rules, regulations, orders, or ordinances of the United States or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally. 
 “Beneficial Owner” has the meaning set forth in Section 5(b) of this Note. 
 “Change of Control” means the occurrence of any of the following in one or a series of related transactions: (i) an acquisition
after the date hereof by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1) under the Exchange Act) of more than one-third of the voting rights or equity interests in the Company other than pursuant to the
Transaction Documents; (ii) a replacement of more than one-half of the members of the Company’s board of directors in a twelve month period in a single election of directors that is not approved by those individuals who are members of the
board of directors on the date hereof (or other directors previously approved by such individuals); (iii) a Fundamental Transaction (as defined in Section 10(c)), a merger or consolidation of the Company or any Subsidiary or a sale of more
than one-half of the assets of the Company in one or a series of related transactions, unless following such transaction or series of transactions, the holders of the Company’s securities prior to the first such transaction continue to hold at
least two-thirds of the voting rights and equity interests in the surviving entity or acquirer of such assets; (iv) a recapitalization, reorganization or other transaction involving the Company or any Subsidiary that constitutes or results in a
transfer of more than one-third of the voting rights or equity interests in the Company, unless following such transaction or series of transactions, the holders of the Company’s securities prior to the first such transaction continue to hold
at least two-thirds of the voting rights and equity interests in the surviving entity or acquirer of such assets and one-half or more of the Board of Directors of the Company remain the same; (v) consummation of a “Rule 13e-3
transaction” as defined in Rule 13e-3 under the Exchange Act with respect to the Company, or (vi) the execution by the Company or its controlling shareholders of an agreement providing for or reasonably likely to result in any of the
foregoing events. 
 “Closing Price” means, for any date, the price determined by the first of the following clauses that
applies: (a) if the Common Stock is then listed or quoted on an Eligible Market, the closing bid price per share of the Common Stock for such date (or the nearest preceding date) on the primary Eligible Market on which the Common Stock is then
listed or quoted; (b) if prices for the Common Stock are then reported in the “Pink Sheets” published by the Pink Sheets, LLC (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid
price per share of the Common Stock so reported; or (c) in all other cases, the fair market value of a share of Common Stock as determined by an independent qualified appraiser selected in good faith and paid for by a majority in interest of
the Investors. 
  

 3 

 “Common Stock” means the common stock of the Company, $0.001 par value per share, and
any securities into which such common stock may hereafter be reclassified. 
 “Company” has the meaning set forth on the
face of this Note. 
 “Conversion Date” means the date a Conversion Notice (together with the Conversion Schedule required
to be attached thereto) is delivered to the Company in accordance with Section 5(a). 
 “Conversion Failure” has
the meaning set forth in Section 6(e) of this Note. 
 “Conversion Notice” means a written notice in the form attached
hereto as Exhibit A. 
 “Conversion Price” means $1.00, subject to adjustment from time to time pursuant to
Section 10. For purposes of determining the Conversion Price of a Euro-denominated Note on any Conversion Date, the Company shall first convert Euros to U.S. Dollars based on the prevailing spot exchange rate published in the Wall Street
Journal on the Conversion Date or, in the absence thereof, such other recognized exchange rate available as of the Conversion Date as the Company may determine. 
 “Conversion Schedule” has the meaning set forth in Section 5(a) of this Note. 
 “Default” means any event or condition which constitutes an Event of Default or that upon notice, lapse of time or both would, unless cured or waived, become an Event of Default. 
 “Distributed Property” has the meaning set forth in Section 10(b) of this Note. 
 “Eligible Market” shall have the same meaning as the term Trading Market set forth in the Purchase Agreement. 
 “Event Equity Value” means the average of the Closing Prices for the five consecutive Trading Days immediately preceding either:
(a) the date of an Event Notice or the date the Company becomes obligated to pay the Event Price under Section 7(b), as applicable, or (b) the date on which the Event Price with respect thereto is paid in full, whichever is greater.

 “Event Notice” has the meaning set forth in Section 7(a) of this Note. 
 “Event Price” has the meaning set forth in Section 7(a) of this Note. 
 “Event of Default” means any one of the following events (whatever the reason and whether it shall be voluntary or involuntary or
effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body): 
  

 4 

 (i) any default in the payment (free of any claim of subordination), when the same
becomes due and payable (whether on a Prepayment Date, the Maturity Date or by acceleration or prepayment or otherwise), of principal under or interest in respect of this Note. 
 (ii) the Company or any Subsidiary (1) fails to pay when due or there is an acceleration of any monetary obligation (regardless of
amount) under any currently existing or hereafter arising debenture (other than a Note) or any mortgage, credit agreement or other facility, indenture agreement, factoring agreement or other instrument under which there may be issued, or by which
there may be secured or evidenced, any Indebtedness or under any long term leasing or factoring arrangement, if the aggregate amount of the obligations and liabilities of the Company and the subsidiaries thereunder exceed $500,000 (each of the
foregoing a “Material Debt Agreement”), or (2) fails to observe or perform any other obligation under any Material Debt Agreement, and such failure results in the obligations thereunder becoming or being
declared due and payable prior to the date on which they would otherwise become due and payable. 
 (iii) the Company shall
fail to observe or perform any covenant, condition or agreement contained in any Transaction Document, and such failure shall continue unremedied for a period of thirty days after the earliest of (i) the date on which written notice of such
default is first given to the Company by the Investor (it being understood that no prior notice need be given in the case of a default that cannot reasonably be cured within thirty days, or (ii) the date the Company discovers or such default or
reasonably should have discovered such default. 
 (iv) the Company creates or suffers to exist any Lien (other than judgment
liens which are covered by clause (ix) below) upon any of its properties, except in accordance with Section 5.2 of the Purchase Agreement. 
 (v) the occurrence and continuance of an Event of Default under any other Note. 
 (vi) the
Company fails to deliver a stock certificate evidencing Underlying Shares to an Investor within five Trading Days after a Conversion Date, or the conversion rights of the Investors pursuant to the terms hereof are otherwise suspended for any reason.

 (vii) any of the Company’s representations and warranties set forth in any Transaction Document shall be incorrect as
of the date made or as of the Original Issue Date. 
 (viii) the occurrence of a Bankruptcy Event. 
 (ix) one or more judgments for the payment of money in an aggregate amount in excess of $250,000 shall be rendered against the Company or
any subsidiary or any combination thereof (which shall not be fully covered by insurance without taking into account any applicable deductibles) and which shall remain undischarged or unbonded for a period of 30 consecutive days during which
execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to attach or levy upon any assets of the Company or any subsidiary to enforce any such judgment. 
  

 5 

 (x) any Transaction Document shall cease, for any reason, to be in full force and effect,
or the Company shall so assert in writing or shall disavow any of its obligations thereunder. 
 (xi) the Common Stock shall
not be listed or quoted, or is suspended from trading, on an Eligible Market for a period of three Trading Days (which need not be consecutive Trading Days). 
 “Fundamental Transaction” has the meaning set forth in Section 10(c) of this Note. 
 “Indebtedness” of any Person shall mean, without duplication, (a) all obligations of such Person for borrowed money or with respect to deposits or advances of any kind, (b) all obligations of such Person evidenced
by bonds, debentures, notes or similar instruments, (c) all obligations of such Person upon which interest charges are customarily paid, (d) all obligations of such Person under conditional sale or other title retention agreements relating
to property or assets purchased by such Person, (e) all obligations of such Person issued or assumed as the deferred purchase price of property or services (other than unsecured accounts payable incurred in the ordinary course of business and
no more than ninety (90) days past the due date set forth in the invoice therefor), (f) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by)
any Lien on property owned or acquired by such Person, whether or not the obligations secured thereby have been assumed, (g) all obligations of such Person in respect of interest rate protection agreements, foreign currency exchange agreements
or other interest or exchange rate hedging arrangements that exceed amounts necessary to hedge the Company’s cross-currency exposure and (h) all obligations of such Person as an account party in respect of letters of credit and
bankers’ acceptances. The Indebtedness of any Person shall include the Indebtedness of any partnership in which such Person is a general partner. 
 “Interest Payment Date” has the meaning set forth in Section 2(a) of this Note. 
 “Investor” has the meaning set forth on the face of this Note. 
 “January Notes” has the meaning
set forth in Section 8(a) of this Note. 
 “Material Debt Agreement” has the meaning set forth within the definition of
Event of Default. 
 “Maturity Date” has the meaning set forth on the fact of this Note. 
 “Maximum Percentage” has the meaning set forth in Section 5(b) of this Note. 
 “Maximum Rate” has the meaning set forth in Section 14 of this Note. 
 “New Note” has the meaning set forth in Section 4 of this Note. 
 “New York Courts” has the meaning set forth in Section 14(b) of this Note. 
 “Original Issue Date” has the meaning set forth on the face of this Note. 
  

 6 

 “Prepayment Date” has the meaning set forth in Section 12 of this Note. 

“Prepayment Notice” has the meaning set forth in Section 12 of this Note. 
 “Proceeding” means a claim, suit, arbitration, investigation or proceeding (including, without limitation, an investigation or partial
proceeding, such as a deposition), whether commenced or threatened. 
 “Purchase Agreement” has the meaning set forth on the
face of this Note. 
 “Register” has the meaning set forth in Section 3 of this Note. 
 “Registered Notes” has the meaning set forth in Section 3 of this Note. 
 “Securities Act” has the meaning set forth on the face of this Note. 
 “Senior Debt” has the meaning set forth in Section 8(b) of this Note. 
 “Trading Day” shall have the meaning set forth in the Purchase Agreement. 
 “Underlying Shares” means the shares of Common Stock issuable upon conversion of the Notes and payment of interest thereunder.

 “VWAP” means, with respect to any date of determination, the daily volume weighted average price (as reported by
Bloomberg using the VAP function) of the Common Stock on such date of determination, or if there is no such price on such date of determination, then the daily volume weighted average price on the date nearest preceding such date. 
 2. Interest. 
 (a) The
Company shall pay interest to the Investor on the aggregate unconverted and then outstanding principal amount of this Note at the rate of 6.5% per annum, payable quarterly in cash, in arrears on each three month anniversary of the Original
Issue Date (each, an “Interest Payment Date”), except if such date is not a Trading Day, in which case such interest shall be payable on the next succeeding Trading Day; provided, further that, during the continuance
of an Event of Default, this Note shall bear interest at the rate of 9.5% per annum. Interest shall be calculated on the basis of a 360-day year for the actual number of days elapsed and shall accrue daily commencing on the Original Issue Date.

 (b) Notwithstanding the foregoing, subject to the conditions and limitations set forth below, in lieu of paying accrued
interest in cash the Company may, at its option, on each Interest Payment Date, pay accrued interest on this Note in kind by increasing the unpaid principal amount of this Note, and interest shall thereafter accrue on this Note on quarterly
compounded basis. The Company must deliver written notice to the Investor indicating the manner in which it intends to pay interest at least ten Trading Days prior to each Interest Payment Date, but the Company may indicate in any such notice that
the election contained therein shall continue for subsequent Interest Payment Dates until rescinded. All interest payable in respect of the Notes on any Interest Payment Date must be paid in the same manner. 
  

 7 

 3. Registration of Notes. The Company shall maintain a register (the
“Register”) for the recordation of the names and addresses of the holders of each Note and the principal amount of the Notes held by such holders (the “Registered Notes”). The entries in the Register
shall be conclusive and binding for all purposes absent manifest error. The Company and the holders of the Notes shall treat each Person whose name is recorded in the Register as the owner of a Note for all purposes, including, without limitation,
the right to receive payments of principal and interest hereunder, notwithstanding notice to the contrary. A Registered Note may be assigned or sold in whole or in part only by registration of such assignment or sale on the Register. Upon its
receipt of a request to assign or sell all or part of any Registered Note by a holder, the Company shall record the information contained therein in the Register and issue one or more new Registered Notes in the same aggregate principal amount as
the principal amount of the surrendered Registered Note to the designated assignee or transferee pursuant to Section 4. 
 4.
Registration of Transfers and Exchanges. The Company shall register the transfer of any portion of this Note in the Register upon surrender of this Note to the Company at its address for notice set forth herein. Upon any such registration or
transfer, a new Note, in substantially the form of this Note (any such new debenture, a “New Note”), evidencing the portion of this Note so transferred shall be issued to the transferee and a New Note evidencing
the remaining portion of this Note not so transferred, if any, shall be issued to the transferring Investor. The acceptance of the New Note by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and
obligations of a holder of a Note. The Company agrees that its prior consent is not required for the transfer of any portion of this Note; provided, however, that the Company shall be entitled to reasonable assurance, including an opinion of
counsel reasonably acceptable to the Company, that such transfer complies with applicable federal and state securities laws. This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as
requested by the Investor surrendering the same. No service charge or other fee will be imposed in connection with any such registration of transfer or exchange. 
 5. Conversion. 
 (a) At the Option of the Investor. All or any portion of the
principal amount of this Note then outstanding together with any accrued and unpaid interest hereunder shall be convertible into shares of Common Stock at the Conversion Price (subject to the limitation set forth in Section 5(b)), at the option
of the Investor, at any time and from time to time from and after the Original Issue Date. The Investor may effect conversions under this Section 5(a) by delivering to the Company a Conversion Notice together with a schedule in the form of
Schedule 1 attached hereto (the “Conversion Schedule”). If the Investor is converting less than all of the principal amount represented by this Note, or, if a conversion hereunder may not be effected in
full due to the application of Section 5(b), the Company shall honor such conversion to the extent permissible hereunder and shall promptly deliver to the Investor a Conversion Schedule indicating the principal amount which has not been
converted. 
 (b) Certain Conversion Restrictions. Notwithstanding anything to the contrary contained herein, the
number of shares of Common Stock that may be acquired by an Investor upon each conversion of Notes (or otherwise in respect hereof) shall be limited to the extent necessary to ensure that, following such conversion (or other issuance), the total
number of shares of Common Stock then beneficially owned by such Investor and its Affiliates and any 

  

 8 

 
other Persons whose beneficial ownership of Common Stock would be aggregated with such Investor’s for purposes of Section 13(d) of the Exchange Act
(“Beneficial Ownership”), does not exceed 4.99% of the total number of issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such conversion) (subject to change as
described below, the “Maximum Percentage”). For the avoidance of doubt, except as otherwise provided herein in connection with a Fundamental Transaction, this Note may not be converted in whole or in part if the
Investor’s Beneficial Ownership (as calculated herein) exceeds the Maximum Percentage prior to such exercise. For such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules
and regulations promulgated thereunder. This provision shall not restrict the number of shares of Common Stock which an Investor may receive or beneficially own in order to determine the amount of securities or other consideration that such Investor
may receive in the event of a Fundamental Transaction (defined below) involving the Company. For any reason at any time, upon the written or oral request of the Investor, the Company shall within one (1) Business Day confirm orally and in
writing to the Investor the number of shares of Common Stock then outstanding. This restriction may not be waived, and notwithstanding anything to the contrary in any Transaction Document, may not be amended by agreement of the parties. To the
extent that the limitation contained in this Section 5(b) applies, the determination of whether this Note is convertible (in relation to other securities owned by such Investor together with any Affiliates) and of which a portion of this Note
is convertible shall be in the sole discretion of a Investor, and the submission of a Conversion Notice shall be deemed to be each Investor’s determination of whether this Note is convertible (in relation to other securities owned by such
Investor together with any Affiliates) and of which portion of this Note is convertible, in each case subject to such aggregate percentage limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination
other than its obligation in this Section 5(b) above to, upon the Investor’s request, confirm orally and in writing to the Investor the number of shares of Common Stock then outstanding. 
 6. Mechanics of Conversion. 
 (a) The number of Underlying Shares issuable upon any conversion hereunder shall equal the outstanding principal amount of this Note to be converted, divided by the Conversion Price on the Conversion Date, plus (if indicated in the
applicable Conversion Notice) the amount of any accrued but unpaid interest on this Note through the Conversion Date, divided by the Conversion Price on the Conversion Date. 
 (b) The Company shall, by the third Trading Day following each Conversion Date, issue or cause to be issued and cause to be delivered to
or upon the written order of the Investor and in such name or names as the Investor may designate a certificate for the Underlying Shares issuable upon such conversion, free of restrictive legends if at such time a registration statement is then
effective and available for use by the Investor. The Investor, or any Person so designated by the Investor to receive Underlying Shares, shall be deemed to have become holder of record of such Underlying Shares as of such Conversion Date. The
Company shall use its best efforts to deliver Underlying Shares hereunder electronically (via a DWAC) through the Depository Trust Corporation or another established clearing corporation performing similar functions. 
  

 9 

 (c) The Investor shall not be required to deliver the original Note in order to effect a
conversion hereunder. Execution and delivery of the Conversion Notice shall have the same effect as cancellation of the Note and issuance of a New Note representing the remaining outstanding principal amount. 
 (d) The Company’s obligations to issue and deliver Underlying Shares upon conversion of this Note in accordance with the terms hereof
are absolute and unconditional, irrespective of any action or inaction by the Investor to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the
same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Investor or any other Person of any obligation to the Company or any violation or alleged violation of law by the Investor or any other
Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Investor in connection with the issuance of such Underlying Shares. 
 (e) If by the third Trading Day after a Conversion Date the Company fails to deliver to the Investor such Underlying Shares in such
amounts and in the manner required pursuant to Section 5(a) (a “Conversion Failure”), then the Investor will have the right, exercisable at any time prior to receipt of the required Underlying Shares, to rescind the
Conversion Notice pertaining thereto by giving written notice to the Company prior to such Investor’s receipt of such Underlying Shares. 
 7. Events of Default; Change of Control. 
 (a) At any time or times following the occurrence and during the
continuance of an Event of Default, the Investor may elect, by notice to the Company (an “Event Notice”), to require the Company to purchase all or any portion of the outstanding principal amount of this Note,
as indicated in such Event Notice, at a purchase price in [Dollars][Euros] in cash equal to the greater of: (A) 102% of such outstanding principal amount, plus all accrued but unpaid interest thereon and any other amounts then owing to the
Investor under the Transaction Documents, through the date of purchase, or (B) the Event Equity Value of the Underlying Shares that would be issuable upon conversion of such principal amount and payment in Common Stock of all such accrued but
unpaid interest thereon (without regard to any condition precedent or conversion limitation contained herein). The aggregate amount payable pursuant to the preceding sentence is referred to as the “Event Price.”
The Company shall pay the aggregate Event Price to the Investor (free of any claim of subordination) no later than the third Trading Day following the date of delivery of the Event Notice, and upon receipt thereof the Investor shall deliver the
original Note so repurchased to the Company. If the Company is unable to redeem all principal, interest and other amounts designated in an Event Notice and such other Event Notices received from other Investors received within seven
(7) Business Days of the Investor’s Event Notice, then the Company shall redeem a pro rata amount from each Investor of the Notes based on the principal amount of the Notes submitted for redemption pursuant to such Event Notice and such
other Event Notices received by the Company during such seven (7) Business Day period. Any partial payments made by the Company pursuant to the preceding sentence shall not relieve the Company of the obligation to pay the remaining unpaid
amounts. 
  

 10 

 (b) Upon the occurrence of any Bankruptcy Event with respect to the Company, all
outstanding principal and accrued but unpaid interest on this Note and any other amounts then owing under the Transaction Documents shall immediately become due and payable in full in [Dollars][Euros] in cash (free of any claim of subordination),
without any action by the Investor, and the Company shall immediately be obligated to repurchase this Note held by such Investor at the Event Price pursuant to the preceding paragraph as if the Investor had delivered an Event Notice immediately
prior to the occurrence of such Bankruptcy Event. 
 (c) Change of Control. 
 (i) Upon the occurrence or entering into by the Company or any subsidiary, or consummation of, any Change of Control prior to the one year
anniversary of the initial Closing Date, the Investor may elect to require the Company to purchase all or any portion of the outstanding principal amount of this Note, as indicated in such Event Notice, at a purchase price in [Dollars][Euros] in
cash equal to the greater of: (A) 125% of such outstanding principal amount, plus all accrued but unpaid interest thereon and any other amounts then owing to the Investor under the Transaction Documents, through the date of purchase, or
(B) the Event Equity Value of the Underlying Shares that would be issuable upon conversion of such principal amount and payment in Common Stock of all such accrued but unpaid interest thereon (without regard to any condition precedent or
conversion limitation contained herein). 
 (ii) Upon the occurrence or entering into by the Company or any subsidiary, or
consummation of, any Change of Control between the one year and two year anniversaries of the initial Closing Date, the Investor may elect to require the Company to purchase all or any portion of the outstanding principal amount of this Note, as
indicated in such Event Notice, at a purchase price in [Dollars] [Euros] in cash equal to the greater of: (A) 120% of such outstanding principal amount, plus all accrued but unpaid interest thereon and any other amounts then owing to the
Investor under the Transaction Documents, through the date of purchase, or (B) the Event Equity Value of the Underlying Shares that would be issuable upon conversion of such principal amount and payment in Common Stock of all such accrued but
unpaid interest thereon (without regard to any condition precedent or conversion limitation contained herein). 
 (iii) Upon
the occurrence or entering into by the Company or any subsidiary, or consummation of, any Change of Control between the two year and three year anniversaries of the initial Closing Date, the Investor may elect to require the Company to purchase all
or any portion of the outstanding principal amount of this Note, as indicated in such Event Notice, at a purchase price in [Dollars] [Euros] in cash equal to the greater of: (A) 115% of such outstanding principal amount, plus all accrued but
unpaid interest thereon and any other unpaid amounts then owing to the Investor under the Transaction Documents, through the date of purchase, or (B) the Event Equity Value of the Underlying Shares that would be issuable upon conversion of such
principal amount and payment in Common Stock of all such accrued but unpaid interest thereon (without regard to any condition precedent or conversion limitation contained herein). 
 (iv) Upon the occurrence or entering into by the Company or any subsidiary, or consummation of, any Change of Control following the three
year anniversary of the initial Closing Date, the Investor may elect to require the Company to purchase all or any portion of the outstanding principal amount of this Note, as indicated in such Event Notice, at a purchase price in [Dollars] [Euros]
in cash equal to the greater of: (A) 102% of such outstanding 

  

 11 

 
principal amount, plus all accrued but unpaid interest thereon and any other amounts then owing to the Investor under the Transaction Documents, through the
date of purchase, or (B) the Event Equity Value of the Underlying Shares that would be issuable upon conversion of such principal amount and payment in Common Stock of all such accrued but unpaid interest thereon (without regard to any
condition precedent or conversion limitation contained herein). 
 (v) If any Investor makes an election under
Section 7(c) of that Investor’s Note, then the Company shall provide notice of such election to all other Investors. 
 (d) In connection with any Event of Default, the Investor need not provide and the Company hereby waives any presentment, demand, protest or other notice of any kind (other than the Event Notice), and the Investor may immediately enforce
any and all of its rights and remedies hereunder and all other remedies available to it under applicable law. Any such declaration may be rescinded and annulled by the Investor at any time prior to payment hereunder. No such rescission or annulment
shall affect any subsequent Event of Default or impair any right consequent thereto. 
 8. Ranking; Subordination. 
 (a) This Note ranks pari passu with all other Notes now or hereafter issued pursuant to the Transaction Documents, all of which are
subordinate to the Company’s Senior Convertible Promissory Notes due January 12, 2012 and issued on January 12, 2007 (the “January Notes”). Except as otherwise contemplated by the Transaction Documents, after
the Company repays amounts due under the January Notes, the Company shall repay amounts due under this Note and all other Notes issued pursuant to the Transaction Documents, on a pro rata basis, based upon the relative unpaid principal balances
thereof then due. The Company will not, directly or indirectly, enter into, create, incur, assume or suffer to exist any indebtedness of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest
therein or any income or profits therefrom, that is senior or pari passu in any respect to the Company’s obligations under the Notes other than Permitted Indebtedness, including the January Notes. 
 (b) The Investor, for itself and its permitted successors and assigns, by acceptance of this Note, agrees that the payment of principal
and interest on this Note (other than payment of interest in kind or in securities) is expressly subordinate and subject to the prior payment in full of the January Notes, including all renewals, extensions, refinancings, increases and replacements
of such Indebtedness (collectively, the “Senior Debt”), whether existing on the date hereof or thereafter issued, incurred, created, assumed and, accordingly, the Investor agrees not to accept cash payment of all or any part
of the principal or interest on this Note until after payment in full of such senior Indebtedness. The provisions of this Note shall be binding upon all persons who, in reliance upon such provisions, become holders of, or continue to hold, the
Senior Debt; such provisions are made for the benefit of the holders of the Senior Debt. Upon written request of the Company, Investors will, within 10 days of such request, execute and deliver such further instruments as may be reasonably required
by the holder or holders of the Senior Debt to evidence and confirm that the obligations evidenced by this Note are subordinate to the Senior Debt. If, prior to satisfaction of the Senior Debt, the Investor receives any payment or security for or on
account of claims and demands of the Investor against the Company, the Investor shall immediately deliver such payments or security to the collateral agent appointed on 

  

 12 

 
behalf of the holders of the Senior Debt (the “Agent”) in the form received, except for the endorsement when necessary for
application and until so delivered, such payment or security shall be held in trust by the Investor as property of such Agent, acting on behalf of such holders. 
 9. Reservation of Underlying Shares. The Company covenants that it will, subject to the exceptions set forth in the Purchase Agreement, at all times reserve and keep available out of the aggregate of its
authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Underlying Shares as required hereunder, the number of Underlying Shares which are then issuable and deliverable upon the conversion of
(and otherwise in respect of) this entire Note (taking into account the adjustments of Section 10), free from preemptive rights or any other contingent purchase rights of persons other than the Investor. The Company covenants that all
Underlying Shares so issuable and deliverable shall, upon issuance in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and nonassessable. 
 10. Certain Adjustments. The Conversion Price is subject to adjustment from time to time as set forth in this Section 10. 
 (a) Stock Dividends and Splits. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend on its
Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, or (iii) combines outstanding shares
of Common Stock into a smaller number of shares, then in each such case the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and of
which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the
determination of shareholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or
combination. 
 (b) Pro Rata Distributions. If the Company, at any time while this Note is outstanding, distributes to
all holders of Common Stock (i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Stock covered by the preceding paragraph), (iii) rights or warrants to subscribe for or purchase any security, or
(iv) any other asset (in each case, “Distributed Property”), then, at the request of the Investor delivered before the 90th day after the record date fixed for determination of shareholders entitled to
receive such distribution, the Company will deliver to the Investor, within five Trading Days after such request (or, if later, on the effective date of such distribution), the Distributed Property that the Investor would have been entitled to
receive in respect of the Underlying Shares for which this Note could have been converted immediately prior to such record date. If such Distributed Property is not delivered to the Investor pursuant to the preceding sentence, then upon any
conversion of this Note that occurs after such record date, the Investor shall be entitled to receive, in addition to the Underlying Shares otherwise issuable upon such conversion, the Distributed Property that the Investor would have been entitled
to receive in respect of such number of Underlying Shares had the Investor been the record holder of such Underlying Shares immediately prior to such record date. Notwithstanding the foregoing, this Section 10(b) shall not apply to any
distribution of rights or securities in respect of adoption by the Company of a shareholder rights plan, which events shall be covered by Section 10(a). 
  

 13 

 (c) Fundamental Transactions. If, at any time while this Note is outstanding,
(i) the Company effects any merger or consolidation of the Company with or into another Person, (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock tender or exchange their shares for other securities, cash or property, or (iv) the Company effects any reclassification
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common
Stock covered by Section 10(a) above) (in any such case, a “Fundamental Transaction”), then the Investor shall have the right to: (x) declare an Event of Default pursuant to clause
(iii) thereunder, or (y) upon any subsequent conversion of this Note, receive, for each Underlying Share that would have been issuable upon such conversion absent such Fundamental Transaction, the same kind and amount of securities, cash
or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of one share of Common Stock (the “Alternate
Consideration”) or (z) require the surviving entity to issue to the Investor an instrument identical to this Note (with an appropriate adjustment to the conversion price) such that the Investor may receive shares of the
surviving company’s common stock. For purposes of any such conversion, the Company shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Investor shall be given the same choice as to the Alternate Consideration it
receives upon any conversion of this Note following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company or surviving entity in such Fundamental Transaction (or, if different, the
ultimate parent of such successor or entity or the entity issuing the Alternate Consideration) shall issue to the Investor a new debenture consistent with the foregoing provisions and evidencing the Investor’s right to convert such debenture
into Alternate Consideration. The terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this paragraph (c) and
insuring that this Note (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction. 
 (d) Reclassifications; Share Exchanges. In case of any reclassification of the Common Stock, or any compulsory share exchange
pursuant to which the Common Stock is converted into other securities, cash or property (other than compulsory share exchanges which constitute Change of Control transactions), the Investors of the Notes then outstanding shall have the right
thereafter to convert such shares only into the shares of stock and other securities, cash and property receivable upon or deemed to be held by holders of Common Stock following such reclassification or share exchange, and the Investors shall be
entitled upon such event to receive such amount of securities, cash or property as a holder of the number of shares of Common Stock of the Company into which such shares of Notes could have been converted immediately prior to such reclassification
or share exchange would have been entitled. This provision shall similarly apply to successive reclassifications or share exchanges. 
  

 14 

 (e) Calculations. All calculations under this Section 10 shall be made to the
nearest cent or the nearest 1/100th of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company, and the disposition of any such shares
shall be considered an issue or sale of Common Stock. 
 (f) Notice of Adjustments. Upon the occurrence of each
adjustment pursuant to this Section 10, the Company at its expense will promptly compute such adjustment in accordance with the terms hereof and prepare a certificate describing in reasonable detail such adjustment and the transactions giving
rise thereto, including all facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Investor. 
 11. Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Underlying Shares on conversion of this Note.
If any fraction of an Underlying Share would, except for the provisions of this Section, be issuable upon conversion of this Note or payment of interest hereon, the number of Underlying Shares to be issued will be rounded up to the nearest whole
share. 
 12. Prepayment. If at any time following the three year anniversary of the Original Issue Date: (i) the VWAP of the
Common Stock for 20 Trading Days during any 30 consecutive Trading Day period (each of which Trading Days must occur following the three year anniversary of the Original Issue Date) ending on the Trading Day immediately preceding the date on which
the Prepayment Notice (as defined below) is delivered by the Company, is greater than 175% of the Conversion Price (subject to adjustment pursuant to Section 10), and (ii) the average daily trading volume for the Common Stock for the 30
Trading Day period referenced in clause (i) above is 40,000 shares, then, subject to the conditions set forth in this Section, the Company may, in its sole discretion, elect to prepay this Note, in whole or in part, by paying to the Investor,
in immediately available funds, 102% of the then outstanding principal amount (or portion thereof as applicable), plus all accrued but unpaid interest, due under this Note, on the date that is the fifth Trading Day after written notice thereof (a
“Prepayment Notice”) is received by the Investor (such fifth Trading Day shall be known as the “Prepayment Date”) at the address last shown on the records of the Company for
the Investor or given by the Investor to the Company for the purpose of notice; provided, that the conditions to giving such notice must be in effect at all times during the entire 30 Trading Day period referenced in (i) above through
the expiration of the Prepayment Date (other than as to clause (i) above which only needs to be satisfied up to the time of the delivery of the Prepayment Notice) or any such Prepayment Notice shall be null and void. Under no circumstances may
the Company deliver more than one Prepayment Notice in any 90 calendar day period. 
 13. Notices. Any and all notices or other
communications or deliveries hereunder (including without limitation any Conversion Notice) shall be in writing and shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is
delivered via e-mail or via facsimile at the facsimile number specified in this Section prior to 5:30 p.m. (New York City time) on a Trading Day, (ii) the next Trading Day 

  

 15 

 
after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on a day that is
not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service, or (iv) upon actual receipt by the party to
whom such notice is required to be given. The addresses for such communications shall be: (i) if to the Company, to 1400 North Providence Road, Suite 6010, Media, Pennsylvania, 19063, facsimile: (610) 565-7081, attention: Chief Financial
Officer, (ii) if to the Investor, to the address or facsimile number appearing on the Company’s shareholder records or such other address or facsimile number as the Investor may provide to the Company in accordance with this Section.

 14. Miscellaneous. 
 (a) This Note shall be binding on and inure to the benefit of the parties hereto and their respective successors and assigns. Nothing in this Note shall be construed to give to any person or corporation other than the
Company and the Investor and their respective successors and assigns any legal or equitable right, remedy or cause under this Note. This Note shall inure to the sole and exclusive benefit of the Company and the Investor. 
 (b) All questions concerning the construction, validity, enforcement and interpretation of this Note shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all Proceedings shall be commenced exclusively in the state and federal courts sitting
in the City of New York, Borough of Manhattan (the “New York Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for any Proceeding, and hereby irrevocably
waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any New York Court or that a New York Court is an inconvenient forum for such Proceeding. Each party hereto hereby irrevocably
waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for
notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by
law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal Proceeding. The prevailing party in a Proceeding shall be reimbursed by the other party for its
reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding. 
 (c) The headings herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect any of the provisions hereof. 
 (d) In case any one or more of the provisions of this Note shall be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Note shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially
reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Note. 
  

 16 

 (e) Terms of this Note may be amended or waived by the Required Purchasers, provided,
however that no provision of this Note may be waived or amended except in accordance with the requirements set forth in the Purchase Agreement, and if the waiver or amendment would alter the unpaid principal balance, the interest rate or the
Maturity Date of this Note, in a written instrument signed, in the case of an amendment, by the Company and the Investor or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought. No waiver of any default with
respect to any provision, condition or requirement of this Note shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or
omission of either party to exercise any right hereunder in any manner impair the exercise of any such right. Notwithstanding the foregoing, Sections 8, 14(a) and 14(e) of this Note may not be amended, modified or supplemented and no amendment,
modification, supplement or waiver affecting Sections 8, 14(a) and 14(e) may otherwise be provided without the prior written consent of the Agent. 
 (f) To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts to be compelled to take the benefit or advantage
of, usury laws wherever enacted, now or at any time hereafter in force, in connection with any claim, action or Proceeding that may be brought by any Investor in order to enforce any right or remedy under the Notes. Notwithstanding any provision to
the contrary contained in the Notes, it is expressly agreed and provided that the total liability of the Company under the Notes for payments in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the
“Maximum Rate”), and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company
may be obligated to pay under the Notes exceed such Maximum Rate. It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Notes is increased or decreased by statute or any official governmental action
subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate of interest applicable to the Notes from the effective date forward, unless such application is precluded by applicable law. If under
any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Investor with respect to indebtedness evidenced by the Notes, such excess shall be applied by such Investor to the unpaid principal balance of any
such indebtedness or be refunded to the Company, the manner of handling such excess to be at such Investor’s election. 
 (g) Unless expressly stated in this Note to the contrary, nothing in this Note, whether express or implied, is intended to confer any rights or remedies under or by reason of this Note on any persons other than the holder of this Note and
its legal representatives, successors and permitted assigns. Notwithstanding the foregoing, the holders of the Senior Debt are the express third party beneficiaries of Sections 8 and 14(e) of this Note. 
 {Signature Page Follows} 
  

 17 

 IN WITNESS WHEREOF, the Company has caused this Note to be duly executed by a duly authorized officer as
of the date first above indicated. 
  

			
	SYNOVA HEALTHCARE GROUP, INC.
		
	By:	 	 
		 	Name:
		 	Title:

 {Signature Page to Series B Note} 
  

 18 

 EXHIBIT A 
 CONVERSION NOTICE 
 (To be Executed by the Registered Investor 
 in order to convert Notes) 
 The undersigned hereby elects to convert the principal amount of Note indicated
below, into shares of Common Stock of Synova Healthcare Group, Inc., as of the date written below. If shares are to be issued in the name of a Person other than undersigned, the undersigned will pay all transfer taxes payable with respect thereto
and is delivering herewith such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will be charged to the Investor for any conversion, except for such transfer taxes, if any. All terms used in this
notice shall have the meanings set forth in the Note. 
  

											
	Conversion calculations:	 	 
		 		 		 	Date to Effect Conversion
				
		 		 		 	 
		 		 		 	Principal amount of Note owned prior to conversion
				
		 		 		 	 
		 		 		 	Principal amount of Note to be Converted
				
		 		 		 	 
		 		 		 	Principal amount of Note remaining after Conversion
				
		 		 		 	 
		 		 		 	DTC Account
				
		 		 		 	 
		 		 		 	Number of shares of Common Stock to be Issued
				
		 		 		 	 
		 		 		 	Applicable Conversion Price
				
		 		 		 	 
		 		 		 	Name of Investor
					
		 		 		 	By:	 	 
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	

  

 19 

 Schedule 1 
 Synova Healthcare Group, Inc. 
 6.5% Senior Convertible Promissory Notes, Series B, due September 19,
2012 
 CONVERSION SCHEDULE 
 This
Conversion Schedule reflects conversions made under the above referenced Notes. 
 Dated: 
  

							
	 Date of Conversion
	  	Amount of
Conversion	  	Aggregate
Principal
Amount
Remaining
Subsequent to
Conversion	  	Applicable Conversion
Price
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	

  

 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]